Interpace Biosciences, Inc. - stock earnings
IDXG Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 175000 USD | 11.0 million USD |
| 2023Q1 | 351000 USD | 9.8 million USD |
| 2022Q4 | -1.6 million USD | 8.3 million USD |
| 2022Q3 | -14.2 million USD | 8.2 million USD |
| 2022Q2 | -3.9 million USD | 9.4 million USD |
| 2022Q1 | -2.2 million USD | 10.4 million USD |
| 2021Q4 | -3.7 million USD | 10.9 million USD |
| 2021Q3 | -3.6 million USD | 9.5 million USD |
| 2021Q2 | -3.4 million USD | 11.2 million USD |
| 2021Q1 | -4.2 million USD | 9.8 million USD |
| 2020Q4 | -6.2 million USD | 8.2 million USD |
| 2020Q3 | -6.2 million USD | 8.2 million USD |
| 2020Q2 | -5.6 million USD | 5.4 million USD |
| 2020Q1 | -6.5 million USD | 9.1 million USD |
| 2019Q4 | -10.7 million USD | 4.2 million USD |
| 2019Q3 | -7.4 million USD | 7.7 million USD |
| 2019Q2 | -5.2 million USD | 6.3 million USD |
| 2019Q1 | -3.4 million USD | 6.0 million USD |
| 2018Q4 | -4.0 million USD | 5.8 million USD |
| 2018Q3 | -3.0 million USD | 5.8 million USD |
| 2018Q2 | -1.9 million USD | 5.5 million USD |
| 2018Q1 | -3.2 million USD | 4.8 million USD |
| 2017Q4 | -5.0 million USD | 4.4 million USD |
| 2017Q3 | -3.3 million USD | 4.2 million USD |
| 2017Q2 | -6.3 million USD | 3.9 million USD |
| 2017Q1 | 2.4 million USD | 3.5 million USD |
| 2016Q4 | 6.3 million USD | 3.1 million USD |
| 2016Q3 | -7.5 million USD | 3.3 million USD |
| 2016Q2 | -2.3 million USD | 3.6 million USD |
| 2016Q1 | -4.8 million USD | 3.0 million USD |
| 2015Q4 | 4.4 million USD | -101.9 million USD |
| 2015Q3 | -4.9 million USD | 36.6 million USD |
| 2015Q2 | -7.0 million USD | 36.3 million USD |
| 2015Q1 | -3.9 million USD | 38.3 million USD |
| 2014Q4 | -7.5 million USD | 26.3 million USD |
| 2014Q3 | -4.3 million USD | 29.2 million USD |
| 2014Q2 | -2.7 million USD | 31.6 million USD |
| 2014Q1 | -1.6 million USD | 32.8 million USD |
| 2013Q4 | -3.7 million USD | 36.4 million USD |
| 2013Q3 | -2.1 million USD | 34.3 million USD |
| 2013Q2 | -883000 USD | 37.2 million USD |
| 2013Q1 | 2.1 million USD | 42.9 million USD |
| 2012Q4 | -23.8 million USD | 35.6 million USD |
| 2012Q3 | -1.0 million USD | 31.8 million USD |
| 2012Q2 | -439000 USD | 27.8 million USD |
| 2012Q1 | -272000 USD | 31.7 million USD |
| 2011Q4 | -10.3 million USD | 38.3 million USD |
| 2011Q3 | -202000 USD | 37.2 million USD |
| 2011Q2 | -895000 USD | 40.6 million USD |
| 2011Q1 | ? USD | 44.3 million USD |
| 2010Q4 | ? USD | 44.7 million USD |
| 2010Q3 | ? USD | 36.0 million USD |
| 2010Q2 | ? USD | 32.8 million USD |
| 2010Q1 | ? USD | 31.1 million USD |
| 2009Q4 | ? USD | 23.1 million USD |
| 2009Q3 | ? USD | 19.6 million USD |
| 2009Q2 | ? USD | 14.1 million USD |
| 2009Q1 | ? USD | 23.5 million USD |
| 2008Q4 | ? USD | 25.4 million USD |
| 2008Q3 | ? USD | 24.5 million USD |
| 2008Q2 | ? USD | 30.4 million USD |
| 2008Q1 | ? USD | 32.2 million USD |
| 2007Q4 | ? USD | 32.6 million USD |
| 2007Q3 | ? USD | 24.0 million USD |
| 2007Q2 | ? USD | 27.8 million USD |
| 2007Q1 | ? USD | 32.8 million USD |
| 2006Q4 | 4.8 million USD | 55.8 million USD |
| 2006Q3 | 463000 USD | 51.3 million USD |
| 2006Q2 | 895000 USD | 55.0 million USD |
| 2006Q1 | 5.6 million USD | 77.1 million USD |
| 2005Q4 | ? USD | 78.3 million USD |
| 2005Q3 | -4.5 million USD | 72.9 million USD |
| 2005Q2 | 4.5 million USD | 76.1 million USD |
| 2005Q1 | ? USD | 78.0 million USD |
| 2004Q4 | 4.6 million USD | 87.8 million USD |
| 2004Q3 | 5.5 million USD | 92.5 million USD |
| 2004Q2 | 5.0 million USD | 91.5 million USD |
| 2004Q1 | 6.0 million USD | 92.6 million USD |
| 2003Q4 | 4.5 million USD | 99.2 million USD |
| 2003Q3 | 4.2 million USD | 94.6 million USD |
| 2003Q2 | 2.8 million USD | 77.6 million USD |
| 2003Q1 | 778000 USD | 73.1 million USD |
| 2002Q4 | ? USD | 79.0 million USD |
| 2002Q3 | ? USD | 64.6 million USD |
| 2002Q2 | ? USD | 66.5 million USD |
| 2002Q1 | ? USD | 73.9 million USD |
| 2001Q4 | 8.3 million USD | 263.9 million USD |
| 2001Q3 | -4.4 million USD | 115.7 million USD |
| 2001Q2 | 4.4 million USD | 143.9 million USD |
| 2001Q1 | 10.9 million USD | 173.1 million USD |
| 2000Q4 | 10.9 million USD | 185.4 million USD |
| 2000Q3 | 5.7 million USD | 84.4 million USD |
| 2000Q2 | 4.8 million USD | 75.8 million USD |
| 2000Q1 | 5.6 million USD | 71.3 million USD |
IDXG Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -22.0 million USD | 31.8 million USD |
| 2021 | -14.9 million USD | 41.3 million USD |
| 2020 | -26.5 million USD | 32.4 million USD |
| 2019 | -26.7 million USD | 24.2 million USD |
| 2018 | -12.2 million USD | 21.9 million USD |
| 2017 | -12.2 million USD | 15.9 million USD |
| 2016 | -8.3 million USD | 13.1 million USD |
| 2015 | -11.4 million USD | 9.4 million USD |
| 2014 | -16.1 million USD | 119.9 million USD |
| 2013 | -4.6 million USD | 150.8 million USD |
| 2012 | -25.5 million USD | 126.9 million USD |
| 2011 | -11.9 million USD | 157.3 million USD |
| 2010 | ? USD | 144.7 million USD |
| 2009 | ? USD | 84.9 million USD |
| 2008 | ? USD | 112.5 million USD |
| 2007 | ? USD | 117.1 million USD |
| 2006 | 11.8 million USD | 239.2 million USD |
| 2005 | ? USD | 319.4 million USD |
| 2004 | 21.1 million USD | 364.4 million USD |
| 2003 | 12.3 million USD | 344.5 million USD |
| 2002 | ? USD | 284.0 million USD |
| 2001 | 6.4 million USD | 696.6 million USD |
| 2000 | 27.0 million USD | 416.9 million USD |
IDXG
Price: $1.41
52 week price:
Earnings Per Share: -0.43 USD
P/E Ratio: -2.17
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1193
Ebitda: -2.5 millionMarket Capitalization: 6.3 million